To develop a technology that responds to the demand of consumers who want to collect SARSCoV-2 samples without pain, BIO3S, Inc. has a novel "Oral and Nasal Virus Clinical Collection(OVC) technology", for highly sensitive self-diagnosis of COVID-19. The Salivfix solution is onestep technology that does not require additional steps such as antigen extract step and RNA extraction step in an antigen rapid diagnostic tests (Ag-RDTs) and PCR analysis, respectively.
BIO3S, Inc. completed clinical trial in comparing the sensitivity and specificity of collecting virus from COVID-19 patients' mouth using OVC technology, in comparison to collecting virus with conventional nasopharyngeal swab (NPS). We hope our OVC technology leads the self-testing market to diagnosis of respiratory viral infectious disease.

BIO3S

Org chart

Teams

Offices